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Summary
Unexplained bleeding was the primary clinical com-
plaint in 15 dogs diagnosed with A. vasorum and was 
observed in the mouth, as external bleeding, as large 
subcutaneous hematoma, as hemoptysis, in the brain, 
post ovariectomy, as epistaxis, in the anterior ocular 
chamber and on a tracheal intubation tube. In 8 dogs 
the cause of bleeding initially was suspected to be a 
minor trauma or a surgical complication, and various 
surgical approaches had been undertaken to eliminate 
the problem. In only 3 dogs respiratory signs were ob-
served before the bleeding prompted referral. The me-
dian time elapsed between the first recognized clinical 
signs attributed to A. vasorum until diagnosis was 
2 weeks (range1 day to 4 months). Four dogs died, 3 on 
the day of admission and 1 dog 4 days after admission. 
Suspected causes of death were respiratory failure and 
cerebral hemorrhage in 2 dogs each. Four dogs had been 
pre-treated with NSAIDs; of these, 2 dogs developed 
severe hemoptysis (1 died), 1 dog developed brain hem-
orrhage (and died), and 1 dog developed a large subcu-
taneous hematoma with marked anemia. Bleeding at 
various sites may be the only recognized abnormality 
in A. vasorum infection. Without a high index of suspi-
cion, the diagnosis and appropriate therapy may be 
delayed to the point of a fatal outcome. Tests of coagu-
lation were quite variable and the cause of bleeding 
likely multifactorial. 
Keywords: thrombocytopenia, thrombocytopathy, DIC,  
pulmonary hypertension, lymphocytosis
Unerklärliche Blutung als primäres 
klinisches Leiden bei Hunden mit  
einer Angiostrongylus vasorum  
Infektion 
Eine unerklärliche Blutung war das primäre klinische Lei-
den bei 15 Hunden mit einer anschliessenden Diagnose 
einer A. vasorum Infektion. Diese Blutungen wurden in 
der Maulhöhle, als äusserliche Blutungen, als grosse sub-
kutane Hämatome, als Hämoptyse, als Hirnblutung, in-
traabdominal nach Ovariektomie, als Nasenbluten, in der 
vorderen Augenkammer und auf dem Trachealtubus zur 
Intubation beobachtet. Bei 8 Hunden wurde als Grund 
der Blutung initial ein kleines Trauma oder eine chirurgi-
sche Komplikation vermutet, und es waren verschiedene 
chirurgische Eingriffe zur Elimination des Problems un-
ternommen worden. Nur bei 3 Hunden waren respirato-
rische Symptome bemerkt worden, bevor die Blutung zur 
Überweisung geführt hatte. Die mediane verstrichene Zeit 
zwischen der ersten durch A. vasorum verursachten klini-
schen Veränderung bis zur Diagnosestellung betrug 
2 Wochen (1 Tag bis 4 Monate). Vier Hunde starben, 3 am 
Tag der Aufnahme und 1 Hund 4 Tage nach Aufnahme. 
Die vermuteten Todesursachen waren Atemversagen und 
Hirnblutung bei jeweils 2 Hunden. Vier Hunde waren mit 
einem NSAIA vorbehandelt worden; von diesen ent-
wickelten 2 hochgradige Hämoptyse (1 starb), 1 Hund 
entwickelte eine Hirnblutung (und starb), und 1 Hund 
entwickelte ein grosses subkutanes Hämatom mit hoch-
gradiger Anämie. Eine Blutung an einer beliebigen Stelle 
kann die einzige klinische Abnormalität bei einer 
A.vasorum Infektion sein. Ohne einen hohen Verdachts-
moment für diese Erkrankung kann die Diagnose und 
adäquate Behandlung soweit verzögert werden, dass der 
Ausgang letal ist. Der pathophysiologische Grund der 
Blutung ist wahrscheinlich multifaktoriell. 
Schlüsselwörter: Thrombozytopenie, Thrombozytopathie, 
DIC, pulmonäre Hypertonie, Lymphozytose
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Introduction
Angiostrongylus (A.) vasorum is a metastrongylid with a 
wide geographic distribution infecting dogs and related 
canids (Bolt et al., 1994). The up to 25 mm long adult 
worms reside in pulmonary arteries and the right side 
of the heart. After a prepatence period of around 
6–8 weeks, shedding of eggs starts in terminal pulmonary 
arteries (Rosen, 1970). Intense immune reactions against 
eggs and larvae elicit a severe inflammatory response in 
pulmonary arteries and the adjacent pulmonary paren-
chyma with coalescing granulomata, arterial thrombosis 
and bleeding (Prestwood et al., 1981; Mahaffey et al., 
1981; Schnyder et al., 2010). Even though the existence 
of A. vasorum has long been recognized in Switzerland, 
(Eckert and Lämmler, 1972), until around 10 years ago 
it was not an important disease and the diagnosis was 
only rarely made both intra vitam and at necropsy. This 
has changed remarkably over the last decade, and the 
disease is now very commonly diagnosed. Besides in-
creased veterinary practitioner awareness, factors under-
lying this trend could be effect of longterm climate 
change on intermediate host availability and/or parasite 
development rate, increasing dog movement, or increas-
ing transmission through the fox population (Taylor et 
al., 2015).
The clinical course can range from very mild with min-
imal symptoms and spontaneous remission (Prestwood 
et al., 1981) to very severe with rapid deterioration from 
the first observed signs until death (Matos et al., 2016). 
Reasons for quite variable presentation may in part re-
flect quantity of infection, considering that clinical and 
radiographic abnormalities were more severe in heavier 
infected experimental dogs (Schnyder et al. 2010, 
Kranjc et al. 2010). However, there are probably other 
as important factors like repetitive infections and indi-
vidual host immunity and immune response (Kranjc et 
al. 2010).
Furthermore, the organ manifestation can be quite vari-
able (Bolt et al., 1994). In view of the parasite’s typical 
primary localization in pulmonary arteries, expectedly 
the primary or most common clinical presentation is 
respiratory disease with cough or dyspnea. A subset of 
dogs with severe pulmonary vascular and parenchymal 
changes will present with signs of pulmonary hyperten-
sion rather than respiratory compromise. Therefore a 
second important clinical presentation is right-sided 
forward or backward heart failure with weakness, syn-
cope and ascites (Glaus et al., 2010; Borgeat et al., 2015; 
Matos et al., 2016). 
Besides the classic pulmonary (vascular) localization of 
this “heart worm” ectopic migration of larvae is also 
common. A third important organ manifestation is 
CNS disease with signs of meningitis and encephalitis, 
including seizures (Perry et al., 1991; Staebler et al., 
2005; Denk et al., 2009). Some dogs may have ophthal-
mologic abnormalities (Rosenlund et al., 1991; King et 
al., 1994). Finally, a few dogs present with polyuria/
polydipsia due to hypercalcemia, thought to be caused 
by excessive vitamin D production associated with gran-
ulomatous disease (Boag et al., 2005; Adamantos et al., 
2015). 
Considering the pathophysiology of this disease, i.e. 
vasculitis in arteries as a reaction against the eggs and 
larvae, hemostatic abnormalities are an expected con-
sequence. Likewise, pulmonary thrombosis invariably 
has been found in experimentally and naturally infect-
ed dogs and is one explanation for the development of 
pulmonary hypertension (Prestwood et al., 1981; 
Kranjc et al., 2010; Matos et al., 2016). On the other side 
of the hemostasis spectrum, bleeding is an important 
part of the pathophysiologic changes in many dogs. It 
is found (upon necropsy) in the lungs as well as the CNS 
and eyes, depending on the localization of the primary 
disease process in the individual dog (Adamantos et al., 
2015). We have seen several dogs where unexplained 
bleeding was the primary presenting complaint, in 
which A. vasorum infection was not considered initially. 
In some of these dogs the bleeding itself reached a 
life-threatening degree. In other dogs the underlying 
A. vasorum infection further evolved to a life threaten-
ing condition (e.g. respiratory failure) and even death. 
Therefore, it is the goal of this case series to characterize 
A. vasorum infected dogs with the primary complaint 
of unexplained bleeding.
Material and methods
Dogs
Records of dogs that were eventually diagnosed with 
A. vasorum and that were presented with the primary 
complaint of spontaneous or unexplained bleeding were 
analyzed with regard to the individual patients’ clinical 
abnormalities, laboratory and imaging findings. The 
initial presentation and the course of the disease until 
A. vasorum was diagnosed were extracted from the cli-
ents’ history. Between April 2011 and March 2016, 
A. vasorum infection was diagnosed in 15 dogs that had 
been presented with the primary complaint of sponta-
neous or unexplained bleeding. The sex distribution was 
11 females and 4 males. Dogs of all ages were affected, 
but most were young (median age 15 months, range 
6 months to 11 years). Most dogs were medium-sized 
(median 20 kg, range 4–39 kg). Twelve different breeds 
were represented of which Labrador Retrievers (n=3) 
and Siberian Huskies (n=2) were identified more than 
once.
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Table 1: Clinical presentation, radiographic findings, diagnosis, therapy and outcome in 15 dogs with bleeding due to A. vasorum.
Dog Presenting complaint Previous signs Respiratory 
signs
Thoracic rads, 
lung pattern
Dx# Tx Outcome
 1 Miniature 
Pinscher
10m, female 
4 kg
Large unexplained  
hematoma ventral neck/
cranial shoulder
– Dyspnea 3m after 
1st  bleeding
Mild generali-
zed interstitial 
at time of he-
matoma
Snap +
Baerm+
Crystalloids
PanacurR
Prednisolone
ViagraR
VetmedinR
PlavixR
Severe PH 
and death 
on day pre-
sented with 
dyspnea
 2 Mixed- 
breed,
10y, female
18 kg
Large unexplained  
peritarsal hematoma, 
marked anemia
1w prev, lameness hind 
leg, Tx NSAID
None Mild diffuse in-
terstitial
Snap +
Serol +
Ec conc, plasma
PanacurR
Prednisolone
CyklokapronR
Discharged 
after 7d, 
cured
 3 Dalmatian
1.5y, female 
19 kg
Large hematoma ventral 
neck/cranial shoulder 
due to suspected bite 
wound 3d prev
3m prev, unusual blee-
ding at OE; 6w prev pro-
tracted bleeding from 
tongue 
None nd Serol + Doxycycline
PanacurR
Discharged 
after 2d
 4 Weimaraner
8m, female 
23 kg
Ataxia, tetraplegia,  
nystagmus; suspected 
cerebral hemorrhage 
2w prev, sublingual 
bleeding, sutured, 
NSAID
Cough 10d after  
1st bleeding
Interstitial dif-
fuse, alveolar 
peripherally 
caudo-dorsally  
Serol + Crystalloids
PanacurR
Prednisolone
CyklokapronR
Death same 
day, suspect-
ed cerebral 
hemorrhage
 5 English  
Bulldog
2y, male 
36 kg 
Bleeding from gums 1d prev, played with 
brunch, blood in saliva 
Cough same day  
as oral bleeding
Mild generali-
zed interstitial
Smear + 
Serol +
Plasma
Prednisolone
PanacurR
CyklokapronR
Discharged 
after 2d, 
cured
 6 Labrador 
7y, female
25 kg
Large hematoma ventral 
neck
4d prev, sublingual 
bleeding left, sutured; 
2d prev same on the 
right, sutured  
None Mild general-
ized interstitial
Serol + Crystalloids
Vitamine K1 
PanacurR
Discharged 
after 3d, 
cured
 7 Hovawart 
6y, female 
39 kg
Non-stoppable bleeding 
from lip
1d prev, after playing 
with other dog bleeding 
from lip, sutured
Cough when  
excited for 3m
Mild nodular 
interstitial  
caudally
Baerm +
Serol -
Plasma
PanacurR
Prednisolone
CyklokapronR
Discharged 
after 4d, 
cured
 8 Rhodesian 
Ridgeback 
11m, male 
35 kg
Non-stoppable bleeding 
from tail
1w prev, at tip of tail 
non stoppable bleeding; 
4d prev, last tail verte-
bra removed 
None Mild interstitial 
and alveolar left 
caudally
Smear +
Baerm +
Plasma
PanacurR
Prednisolone
CyklokapronR
Discharged 
after 4d, 
cured
 9 Boxer
15m, female 
25 kg
Epistaxis 5w prev, bleeding paw 
after accident, sutured, 
still bleeding after 10d
None Interstitial mul-
tifocal nodular, 
particularly  
caudodorsally
Baerm +
Serol +
Crystalloids
Vitamin K1
PanacurR
Prednisolone
Discharged 
after 6d, 
cured
10 Labrador
6m, male 
20 kg
15 seizures in last 24h, 
blood in endotracheal 
tube at anesthesia for 
CSF tap; CSF normal
Seizures for 3m None Interstitial no-
dular diffuse 
particularly at 
periphery
Serol + Crystalloids
Phenobarbital
AdvocateR
Amoxi-Clav
Death after 
4d
11 Golden  
Retriever, 
1.5y, female
17 kg
Seizures, MRI consistent 
with cerebral hemorrhage; 
CSF xanthochromia and 
mixed inflammation*
4m prev, unexplained 
severe bleeding after 
OE 
None Mild interstitial Serol + PanacurR
AdvocateR
Prednisolone
Amoxi-Clav
Discharged 
after 7d, 
cured
12 Irish Terrier
11y, female
21 kg
Progressive anemia,  
severe bleeding after 
OHE 
1w prev, OE, repeated 
surgery due to bleeding
None Unremarkable Baerm + PanacurR
Amoxi-Clav 
Discharged 
after 7d, 
cured
13 Labrador 
9m, female
20 kg
Severe hemoptysis 2m prev, unilateral blee-
ding into anterior ocular 
chamber;  
2d prev, cough
Cough 2m after 
ocular bleeding
Severe inter-
stitial to alveolar 
in periphery
Serol + PanacurR
Prednisolone
Discharged 
after 5d, 
cured
14 Husky
8m, female
16 kg
Acute severe hemoptysis 3w prev, cough, gone 
with cough sirup and 
NSAID
Cough 3w before 
hemoptysis
na Snap +
Smear +
Plasma
PanacurR
Prednisolone
CyklokapronR
Discharged 
after 3d, 
cured
15 Husky 
8m, male
19 kg
Acute hemorrhagic  
“vomiting”, also pouring 
through nares, shock
Vomiting since puppy, 
cough for 1m, pretrea-
ted with NSAID
Cough 1m before 
bleeding
Generalized se-
vere interstitial, 
alveolar acces-
sory and right 
cranial lobes
Smear +
Serol +
Ec conc
Crystalloids
PanacurR
Prednisolone
Death 5h 
after admis-
sion, profuse 
hemoptysis
y, year; m, month; w, week; d, days; prev, previously; CSF, cerebrospinal fluid, *1.7 g/l protein, 132 cells/ul, mixed population, xanthochromia; OE, ovariec-
tomy; Dx, diagnosis: #Serol, Antigen EIA (Schnyder et al. 2011); Snap, Angio DetectTM ; Baerm, Baermann coprology (Deplazes et al. 2013); smear, direct 
fecal smear examination by emergency doctor; Tx, therapy; nd, not done; na, not available; Ec conc, erythrocyte concentrate.
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Diagnosis and laboratory examinations 
The diagnosis of A. vasorum was confirmed by direct 
fecal smear examination, fecal Baermann examination, 
antigen detection in serum (Schnyder et al., 2011) or a 
pet-side antigen test (Angio DetectTM, Idexx Diavet AG, 
CH-Bäch). Automated hematological analyses were per-
formed on a Sysmex XT 2000i (Sysmex digitana, 
CH-Horgen, except if indicated otherwise pocH-100iV 
Diff, Medical Solution GmbH, Ch-Hünenberg), bio-
chemical analyses were performed on a Cobas 6000 
(Cobas 6000. Roche Diagnostics AG, CH-Rotkreuz). 
Prothrombin time (PT), partial thromboplastin time 
(PTT), thrombin time (TT) and fibrinogen (thrombin 
time Clauss method) were performed on a Diagnostica 
Stago (Diagnostica Stago, Roche Diagnostics AG, 
CH-Rotkreuz). The activated coagulation time (ACT) 
was performed on a Hemochron 401 (Hemochron 401, 
Fresenius AG, CH-Stans). Plasma D-Dimers were meas-
ured using an immunoturbidimetric method on a Cobas 
Integra Cobas Integra, Roche Diagnostics AG, CH-Rot-
kreuz). To measure the buccal mucosal bleeding time 
(BMBT) a standardized mucosal incision was made 
using a spring-loaded device (Surgicutt junior ITC, 
USA-Edison). 
Diagnostic imaging
Brain Magnet Resonance Tomography (MRI) was per-
formed with a 3Tesla system (Ingenia 3T, Philips AG, 
CH-Zurich). Echocardiographic examination (Vivid 7, 
General Electrics, CH-Glattbrugg) to asses for pulmo-
nary hypertension (PH) included qualitative 2-dimen-
sional assessment, spectral Doppler measurements of 
tricuspid and pulmonic insufficiency peak velocities, 
and assessment of the pulmonary artery flow profile as 
described elsewhere (Glaus, 2015).
Results
Clinical presentation 
The sites of bleeding were variable and in some dogs 
occurred in multiple locations (Table 1). In 8 dogs the 
cause of bleeding initially was suspected to be a 
non-specified minor trauma or a surgical complication 
and in these dogs various surgical approaches had been 
undertaken as an attempt to solve the problem. Four 
dogs had received a non-steroidal anti-inflammatory 
drug (NSAID) before the bleeding prompted referral. 
All individual clinical data are specified and detailed in 
Table 1. The median time elapsed between the first re-
cognized clinical signs (retrospectively) attributed to 
A. vasorum until diagnosis was 2 weeks (range 1 day to 
4 months); in only 2 dogs (both with profuse bleeding 
from the oral mucosa) A. vasorum was the prime suspect 
for the spontaneous bleeding.
Based on patient history, respiratory signs were absent 
in 8 dogs. In 3 dogs, cough or dyspnea were observed 
10 days to 3 months after the first bleeding, and in 1 dog 
cough and dyspnea occurred concurrently with the 
bleeding (hemoptysis). In only 3 dogs cough was present 
before bleeding prompted referral; duration of cough 
was 1 to 3 months. 
Course of the disease
The course of disease was variable. After diagnosis, 
11 dogs recovered quickly and uneventfully with an-
tiparasitic and supportive therapy and were discharged 
after a median of 4 days (range 1–7 days). Four dogs 
died, 3 dogs on the day of admission and 1 dog 4 days 
after admission. These 4 dogs had shown signs likely 
caused by A. vasorum for 2 weeks to 3 months, and all 
were young (6–8 months). Suspected causes of death in 
2 dogs each were respiratory failure (1 dog with severe 
PH, and 1 dog with severe hemoptysis) and cerebral 
hemorrhage. Of the 4 dogs that had been pre-treated 
with NSAIDs, 2 dogs were presented with severe hemop-
tysis (one died), 1 dog with brain hemorrhage (and died), 
and 1 dog with a peritarsal hematoma and marked ane-
mia. 
Treatments of the individual dogs are depicted in Ta-
ble 1. The dosage for Fenbendazole (Panacur, MSD 
Animal Health GmbH, CH-Luzern) was 50 mg/kg/day 
for 21 days, for Prednisolone (Streuli, CH-Uznach) 
1 mg/kg/day for 3–5 days, and for Tranexamic acid 
(Cyklokapron, MEDA Pharma GmbH, CH-Wangen) 
20 mg/kg 3×/day for 1–3 days. 
Laboratory findings
Fifteen blood counts were obtained upon admission in 
14 dogs (2 admissions 4 months apart in one dog). The 
individual results are shown detailed in Table 2. The 
median hematocrit was 31% (range 17–47%), and ane-
mia was present in 11 of 15 dogs. Leukocytosis (mostly 
neutrophilic) was present in 12 of 15 dogs, but with one 
exception was only mild to moderate. A left shift was 
present in 5 of 13 samples, but remarkable only in one. 
Eosinophilia was present in 5 of 13, basophilia in 3 of 
11, and monocytosis in 4 of 11 dogs. Only 1 dog showed 
lymphopenia, and 2 dogs showed lymphocytosis. Bio-
chemichal profiles were mostly unremarkable. Only one 
dog showed mild hypoalbuminemia (25 g/l), and one 
dog showed hyperglobulinemia (56 g/l). 
The median thrombocyte count was 118’000/ul (range 
33’000–303’000/ul), and thrombocytopenia was present 
in 7 of 14 dogs. One or several coagulation times were 
obtained in 14 dogs. In most dogs, at least one time of 
coagulation was abnormal, however, coagulation times 
were mostly only mildly prolonged. Only one dog pre-
sented with all measured coagulation times in the nor-
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mal range. The fibrinogen concentration was obtained 
in 8 dogs, and was below the detection limit in 4 of 
8 dogs, normal in 3 of 8 dogs and increased in 1 of 
8 dogs, D-dimers were measured in 3 dogs, and were 
elevated in 2 of these. The individual results of the 
coagulation tests are shown in Table 3.
The diagnosis of A. vasorum infection was confirmed 
serologically in 10 dogs, by pet-side antigen test in 
3 dogs, by fecal Baermann exam in 5 dogs and by a 
direct fecal smear in 4 dogs. In 8 dogs multiple tests were 
performed. Disparity of the test results was found in 
only 1 dog with a positive fecal Baermann, but a negative 
serology result. 
Imaging findings
Thoracic radiographs were available for evaluation in 
13 dogs. In 6 dogs, they were considered unremarkable 
or they showed only a mild interstitial pattern. In seven 
dogs, the radiographs showed peripherally pronounced 
interstitial to alveolar opacifications, typical for A. vaso-
rum infection (table 1). Echocardiography was per-
formed in 8 dogs at the time of bleeding and only one 
had evidence of pulmonary hypertension (PH, TR-PG 
40 mmHg). In one additional dog severe PH was found 
3 months after the unexplained bleeding had been ob-
served. At this time bleeding was no longer detected. 
Discussion
Bleeding diathesis has long been recognized as one pos-
sible clinical manifestation in some dogs with A. vaso-
rum infection (Boag et al., 1994), however, this fact is 
most apparently not broadly appreciated. With reference 
to our case series, in only 2 dogs A. vasorum was con-
sidered a potential cause already at the onset of the 
sometimes excessive bleeding. In the remaining dogs, 
bleeding initially was thought to be due to non-specified 
trauma or iatrogenic from surgery. In view of the risk of 
a fatal outcome, 4 of 15 dogs in our case series, a high 
index of suspicion for this disease is crucial. Unfortun-
Table 2:  Hematologic findings in 15 dogs with spontaneous bleeding due to A. vasorum infection.
Dog Hct
[%]
Leuk
[x103/ul]
Band
[x103/ul]
Seg
[x103/ul]
Eos
[x103/ul]
Baso
[x103/ul]
Mono
[x103/ul]
Lymph
[x103/ul]
 1 Mini Pinscher 
10 m !
– – – – – – – –
 2 Mixed-breed 
10y 
20 40.00 5.60 27.40 2.20 0 2.80 2.00
 3 Dalmatian 
1.5y  
27 13.55 0 9.79 0.54 0.12 0.92 2.18
 4 Weimaraner
8m !
43 21.10 0 14.98 1.06 0 0.84 4.22
 5 English Bulldog 
2y 
45 14.60 0 9.99 1.14 0.02 0.54 2.94
 6 Labrador 
7y
24 10.40 c 0 9.50 c 0.30 c c c 0.60 c
 7 Hovawart 
6y
36 10.90 0.05 5.43 2.17 0.54 0.54 2.12
 8 Ridgeback 
11m
31 26.10 0 14.52 1.91 0.04 1.57 8.04
 9 Boxer 
15m
43 19.20 0.29 16.84 0 0 0.38 1.73
10 Labrador
6m  !
47 19.80 – – – – – –
11 Golden Retriever, 
1.5y
32
40
21.70
15.80
0.11
0
17.79
11.13
0
0.63
0
0
1.95
0.87
1.84
3.16
12 Irish Terrier
11y
17 14.20 0.92 9.87 0.21 0 0.85 2.34
13 Labrador 
9m
24 24.10 0.12 10.84 5.90 1.32 2.53 3.37
14 Husky 
8m
21 23.900 – – – – – –
15 Husky 
8m  !
29 10.500 c 0 5.900 c 1.40 c c c 3.200 c
normal 42–55 4.7–11.3 <0.08 2.5–7.44 0.12–1.29 0–0.08 0.20–0.92 1.15–3.40
! dogs that died; c pocH-100iV Diff 
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ately, clinical signs, imaging findings and routine la-
boratory analyses may be quite unremarkable or non-spe-
cific. In only 4 dogs in this case series, respiratory signs 
that might raise the index of suspicion for an infection 
with pulmonary parasites, were present before or at the 
time of bleeding. Thoracic radiographs were suspicious 
for A. vasorum in only half of the dogs. Eosinophilia 
and basophilia, simple markers of parasitic disease, are 
commonly absent (Schnyder et al. 2010, Glaus et al., 
2010). In the cases of this report, eosinophilia was pres-
ent in only 5 of 13, and basophilia in 3 of 11 samples. 
A remarkable finding in the differential blood count was 
the lack of lymphopenia and even (marked) lymphocy-
tosis in 2 cases despite severe stress of disease. 
The often unremarkable thoracic radiographs may be 
explained in several ways. One explanation is the fact 
that thoracic radiographs may have poor sensitivity to 
detect pulmonary vascular pathology. Some dogs may 
develop severe PH despite quite unremarkable radio-
graphs; however, these dogs have severe pulmonary 
damage visualized by CT and confirmed by histopa-
thology (Matos et al. 2016). The more likely explanation 
is the absence of much pathological changes in the pul-
monary vessels and adjacent parenchyma which is sup-
ported by the fact that many dogs did not show respira-
tory signs. Even though dogs of all ages were present in 
this study, most were young, and the ones with fatal 
outcome were the youngest. This is similar to dogs with 
A. vasorum induced PH, where the most severe PH with 
a fatal outcome more commonly occurred in younger 
dogs (Matos et al., 2016). 
It is interesting to note that some dogs develop a 
life-threatening hypercoagulable and others a hypoco-
agulable state. In a subgroup of infected dogs, clinical 
signs are dominated by the underlying pulmonary (vas-
cular) disease and associated pulmonary artery throm-
bosis. Typically, respiratory signs with cough and dys-
pnea and/or signs of cardiovascular insufficiency due to 
pulmonary hypertension dominate the clinical picture. 
Spontaneous or inappropriate bleeding is usually not 
present in these cases with the exception of hemoptysis 
in some. Furthermore, coagulation times are usually 
normal, in experimentally as well as naturally infected 
dogs (Schnyder et al., 2010, Glaus et al., 2010, Borgeat 
et al., 2015; Matos et al., 2016). In contrast, another 
subgroup of dogs mainly presents with clinical signs 
dominated by bleeding and, like in our case series, ab-
normal coagulation tests are usually present (Chapman 
et al., 2004, Adamantos et al., 2015). 
The exact pathomechanism of bleeding in these dogs is 
not clearly established. Basically, one mechanism may 
be an abnormal primary hemostasis. Immune-mediated 
thrombocytopenia (ITP) has been described in one dog 
where low platelets were the suspected cause of bleeding 
(Gould and McInnes, 1999). In our dogs, thrombocy-
topenia was not considered an important underlying 
cause as platelet counts were above 30’000/ul in all dogs 
Table 3: Coagulation parameters in 15 dogs with bleeding associated with A. vasorum infection.
Dog Tc
[x103/ul]
PT
[sec]
PTT
[sec]
TT
[sec]
Fibrinogen
[g/l]
D-Dimer 
[mg/l]
Other coagu-
lation tests
 1 Miniature Pinscher, 10m! – – – – – – –
 2 Mixed-breed, 10y 42 10.2 17.4 1.0 – –
 3 Dalmatian, 1.5y 61 7.8 12.9 – 1.1 – –
 4 Weimaraner, 8m ! 210 18.2 23.4 23.2 <0.1 – –
 5 English Bulldog, 2y 134 16.0 16.9 – <0.1 – –
 6 Labrador, 7y 149 8.8 12.3 – – – BMBT 2’56’’
ACT 2’54’’
 7 Hovawart, 6y 87 24.1 26.7 28.6 <0.1 0.9 
 8 Rhodesian Ridgeback, 11m 99 13.8 19.5 – <0.1 – –
 9 Boxer, 15m 96 10.7 16.3 – 1.0 – ACT 2’26’’
10 Labrador, 6m ! 303 – – – – – BMBT 1’30’’
11 Golden Retriever, 1.5y 226
157
8.5 
7.8 
14.0
12.5 
16.8 
14.1 
– 0.4 BMBT 1’
12 Irish Terrier, 11j 202 – 14.8 15.9 8.7 – –
13 Labrador, 9m 33 10.6 17.8 – 1.5 
14 Husky, 8m clumped – – – – – –
15 Husky, 8m ! 57 – – – – – ACT 2’26’’
normal 130–394 6.3–8.5 9.6–16.1 12.3–21.6 1.0–2.5 0–0.4 
! dogs that died; Tc, platelets; BMBT, buccal mucosal bleeding time, normal <4’, Kraus and Johnson, 1989; ACT, activated coagulation timef, normal <2’, 
Glaus et al. 1996
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(Scott and Jutkowitz, 2010), and half of the dogs had 
normal platelet counts. However, thrombocytopenia 
may have been a contributing factor in some. Abnormal 
platelet function is an additional possibility. The BMBT 
was normal in 3 dogs, not supporting the presence of a 
thrombopathy at least in these. Nevertheless, iatrogen-
ic abnormal platelet function is one plausible factor in 
the 4 dogs that had received a NSAID before excessive 
bleeding had started. Future studies that include platelet 
function testing in dogs with A. vasorum infection 
would be interesting to further characterize the primary 
hemostasis in these patients.
Another mechanism for the bleeding is an abnormal 
secondary hemostasis. In most dogs, one or several co-
agulation times were prolonged, even though only mild-
ly, consistent with coagulation factor deficiency. Pulmo-
nary thrombosis alone would not explain factor 
deficiency, as indicated above. Disseminated thrombo-
sis, i.e. disseminated intravascular coagulation (DIC), 
was proposed as possible cause (Ramsey et al., 1996; 
Schmitz and Moritz, 2009; Adamantos et al., 2015). 
Disseminated intravascular coagulation is a dynamic 
process, and overt bleeding is typically observed in the 
acute phase. Coagulation tests are quite variable and can 
change over time. In the acute phase PT, PTT and TT 
may be normal to increased, fibrinogen concentration 
may be markedly decreased, normal or increased, and 
D-dimers would be expected to be elevated (Levi et al., 
2009; Rudloff and Kirby, 2014; Kander et al., 2016). 
Acute DIC may explain at least in part the bleedings in 
the dogs of this case series. Considering the generally 
guarded prognosis in dogs with overt DIC, it is still 
somewhat surprising that several dogs had survived their 
bleeding for a prolonged period of time without appro-
priate treatment. If these dogs had DIC, indeed, one 
possible explanation may be the observation that spon-
taneous improvement of vascular lesions occurs in 
A. vasorum infection (Prestwood et al. 1981).
Finally, in addition to abnormalities in primary or sec-
ondary hemostasis, hyperfibrinolysis has been suggested 
as another possible mechanism (Zoia and Caldin, 2015). 
Clinico-pathologically, hyperfibrinolysis would present 
similar to DIC, with mild prolongations of coagulation 
times, elevated D-dimers, and low fibrinogen concentra-
tion. Hyperfibrinolysis is best diagnosed by viscolelastic 
testing such as thromboelastometry (Rotem) (Vorweg et 
al. 2001; Lier et al., 2013). So far, hyperfibrinolysis has 
been described in one dog with A. vasorum infection 
using thromboelastography (TEG) (Schmitz and Moritz, 
2009). A recent study reported TEG results in 30 dogs, 
however, this study did not conclusively prove the pres-
ence of hyperfibrinolysis (Adamantos et al., 2015). At 
any rate, in view of quite variable results of platelet num-
bers, coagulation times, fibrinogen and D-Dimer con-
centrations in dogs bleeding due to A. vasorum infection, 
various mechanisms, including iatrogenic actions, prob-
ably play a pathogenetic role.
Whether thrombosis/DIC or hyperfibrinolysis is the 
most important underlying mechanism in the individ-
ual dog diagnosed with A. vasorum, has some therapeu-
tic importance. If pronounced disseminated thrombosis 
is the primary mechanism, attempts at inhibiting fur-
ther thrombosis and simultaneously providing fresh 
coagulation factors are the suggested approach. In con-
trast, if hyperfibrinolysis is an important mechanism, 
an antifibrinolytic drug like tranexamic acid is the most 
appropriate treatment. There is a theoretic caveat con-
cerning the use of this drug in A. vasorum infection. By 
its mode of action, and shown in an experimental dog 
model, tranexamic acid favors pulmonary thrombosis 
(Moser et al. 1991). Some degree of pulmonary throm-
bosis is invariably present in dogs infected with A. vaso-
rum, and in some may be the cause of heart failure and 
death (Matos et al. 2016). Ideally, at the time of diagno-
sis the presence of hemodynamically important pulmo-
nary thrombosis and associated PH is non-invasively 
evaluated by echocardiography. In the dogs of this se-
ries, tranexamic acid was given in 6 cases as part of the 
treatment, and discernible pulmonary thrombosis was 
not an apparent complication in any. In people, the use 
of tranexamic acid is strongly advised in cases of severe 
traumatic bleeding, even if hyperfibrinolysis is not doc-
umented (Roberts, 2015). 
In conclusion, A. vasorum infection should be consid-
ered in the differential diagnosis in dogs presented with 
unexplained or severe bleeding.
Limitations of the study 
It is not possible to prove that all bleedings in these dogs 
at each time point were caused by A. vasorum, particu-
larly in the dogs that already had shown bleeding 
months before diagnosis. However, no other explana-
tion was found in any of these dogs, and all survivors 
remained free of clinical signs after initiating therapy. 
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